Kawasaki Disease and COVID-19

Area of Science:

• Pediatrics
• Immunology
• Infectious Diseases

Background:

• Kawasaki Disease (KD) is a childhood vasculitis affecting coronary arteries.
• Multisystem Inflammatory Syndrome in Children (MIS-C) is associated with SARS-CoV-2 infection.
• Both conditions present with fever and inflammation, requiring timely differentiation.

Purpose of the Study:

• To provide a timely review of Kawasaki Disease and MIS-C.
• To compare and contrast the clinical features, and treatment of KD and MIS-C.
• To highlight the importance of early diagnosis and management.

Main Methods:

• Literature review of KD and MIS-C.
• Comparative analysis of clinical presentations.
• Summary of current treatment strategies.

Main Results:

• KD presents with fever, rash, conjunctivitis, and potential coronary artery aneurysms.
• MIS-C involves multi-organ dysfunction, resembling KD, toxic shock, and macrophage activation syndrome.
• Treatment for KD includes IV immunoglobulin and aspirin; MIS-C treatments are varied, including IVIg, steroids, and cytokine inhibitors.

Conclusions:

• KD and MIS-C are distinct but share overlapping features, necessitating careful diagnosis.
• Prompt recognition and appropriate treatment are vital for managing these pediatric inflammatory conditions.
• Further research into MIS-C pathogenesis and standardized treatment is warranted.